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ABSTRACT  
The phone-hacking scandal that led to the closure of the News of the World newspaper in Britain has 
prompted international debate about media practices and regulation. It is timely to broaden the 
discussion about journalistic ethics and conduct to include consideration of the impact of media 
practices upon the population’s health. Many commercial organizations cultivate relationships with 
journalists and news organizations with the aim of influencing the content of health-related news 
and information communicated through the media. Given the significant influence of the media on 
the health of individuals and populations, we should be alert to the potential impact of industry-
journalist relationships on health care, health policy and public health. The approach taken by the 
medical profession to its interactions with the pharmaceutical industry provides a useful model for 
management of industry influence. 
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INTRODUCTION: THE CONTEXT 
The phone-hacking scandal that has engulfed News Corporation and led to the closure of its tabloid 
English newspaper, News of the World, has prompted international debate about the practices of 
journalists and media organisations, and has led to calls for more effective media regulation. Much 
of the public discussion has focused on issues of ethics, corporate governance and privacy concerns, 
and there has also been examination of the relationships between journalists/media organisations 
and influential figures in society, including politicians and senior police. In England, an inquiry led by 
a judge, Lord Justice Leveson, is examining media regulation as part of a broader inquiry, which will 
also consider relationships between News International executives and law-makers. In Australia, an 
inquiry into the media is due to report its findings in early 2012. Its terms of reference include: “Any 
related issues pertaining to the ability of the media to operate according to regulations and codes of 
practice, and in the public interest”.[1]  
For those concerned with the impact of media coverage on health, this is a timely 
opportunity to broaden the discussion; and as part of this discussion we should be asking how 
relationships between journalists and commercial entities, such as pharmaceutical and device 
companies and associated experts, affect media coverage and thus influence health policy, 
professional practice and the decisions made by consumers. 
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THE NEED FOR A CRITIQUE OF INDUSTRY-JOURNALIST RELATIONSHIPS 
In recent years, increasing attention has been paid to the scope and impact of conflicts of 
interest in health and medical research. The central concern is that interactions with industry can, 
and do, distort clinicians’ perceptions and fulfilment of their primary obligations to their patients; 
researchers’ primary obligation to generate knowledge; teachers’ primary obligations to their 
students; and policy makers’ primary obligations to the public.[2-4]  
While journalists and media organisations have always been sensitive to the ethical 
dimensions of their relationships with their sources,[5] this attention has not been directed 
specifically towards health reporting or to the extent and impact of commercial sources of 
information on health reporting. 
This is a significant lacuna for two reasons. First, journalists play a major role in shaping the 
public’s understanding of health, illness and disease, as well as expectations about therapies and 
services. Indeed, there is evidence that the impact of the media can exceed that of even high-budget 
government sponsored public health campaigns in shaping people’s health expectations and 
behaviour.[6, 7] Second, like clinicians, researchers, educators and policy-makers, journalists who 
write about health have a number of obligations to the public, including the obligation to inform, to 
provide independent critique, and to do so in a transparent and trustworthy manner. These roles—
as well as trust in the media—can be undermined if journalists have, or are found to have, conflicts 
of interest. These conflicts of interest are likely to be particularly damaging if they involve industry, 
because industry’s primary obligation to its shareholders is likely to be at odds with journalists’ 
primary obligation to the public and to principles of journalism such as integrity, credibility and 
fairness.[8-10]  
For both of these reasons, it is essential that journalists are able to maintain independence 
from their sources (especially commercial sources), and provide information about commercial 
products in a fair, objective and accurate manner.[8-10] To facilitate this, we need to understand the 
nature and scope of industry-journalist relationships and the ways in which industry influences can 
and do distort journalists’ reporting. We also need to devise a comprehensive set of practical 
strategies to manage industry-journalist relationships. 
 
THE NATURE AND SCOPE OF INDUSTRY-JOURNALIST RELATIONSHIPS 
While we do not know the extent of interactions between journalists and the 
pharmaceutical industry, we do know that the entanglements between them are many and varied. 
Pharmaceutical and biotechnology companies are well aware of the power of the news media to 
influence policymakers, consumers and health professionals, and they have a repertoire of strategies 
for interacting with journalists. They recognise that journalists need content and/or access to 
expertise, so they, or their public relations agents, provide press releases, video/audio news releases 
(VNRs), and other information about their products to assist journalists in writing about them, as 
well as access to medical and scientific experts.[9] Companies also interact with journalists more 
directly by means of ‘gifts’, by sponsoring travel to attend conferences and other events, by 
sponsoring journalists’ education and awards for health-related journalism, and by paying journalists 
to write stories for trade journals.[11] 
To give just a few current examples, in the United States, an annual workshop on cancer for 
journalists, run by the National Press Foundation (NPF), is funded by Pfizer. Pfizer also funds an all-
expenses-paid NPF program for journalists on Alzheimer's disease.[12] Also in the United States, the 
University of North Carolina School of Journalism and Mass Communication endowed a Glaxo 
Wellcome Distinguished Professorship of Medical Journalism—Glaxo donating $330,000 to establish 
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the Chair, and the University contributing $167,000. While the Professorial appointment did not 
receive any funding directly from Glaxo Wellcome, the co-sponsorship of this Chair created the 
perception of ethically problematic entanglement.[11, 13] In Australia, the pharmaceutical industry 
peak body, Medicines Australia, is the principal sponsor of the National Press Club’s health 
journalism awards which aim “to create awareness of health, medicine and innovation issues and 
contributions to health science and innovation in Australia.”[14] And in Europe, GlaxoSmithKline 
funds the Irish medical media awards.[11]  
 
THE PROBLEM WITH INDUSTRY-JOURNALIST RELATIONSHIPS 
While there is little direct evidence of public harm resulting specifically from industry-
journalist interactions, there are a number of reasons why we should be concerned about financial 
relationships between journalists and their industry sources. First, we know from other settings that 
industry influence can affect practice. In medicine, for example, there is significant empirical 
evidence that industry relationships affect physicians’ prescribing practices [15] and the reported 
results of industry-funded research.[16] Second, while the media often impart important health 
promotional messages, we know that health-related industries use the media to ‘medicalise’ health 
concerns (thus contributing to ‘disease mongering’);[17] increase consumer demand for unnecessary 
products; obscure the shortcomings or side-effects of products; and divert attention away from 
more pressing health concerns and more effective or less costly (particularly non-pharmacological) 
means of prevention or treatment.[7, 18]  
We also know that journalists are becoming increasingly ‘time-poor’. News organisations do 
not always provide support to specialist medical and health reporters, and there are increasing 
financial constraints upon independent reporting due to (for example) cost-cutting by media outlets 
as a result of collapsing business models in conventional media, and intense competition from 
‘alternative’ sources of news and information.[9, 19, 20] This might make journalists more reliant on 
their sources—including industry sources—for information about products, expert commentary, and 
prepared news releases. 
Not surprisingly, therefore, efforts by pharmaceutical companies to influence journalists 
have been the subject of increasingly intense criticism among practicing journalists, media critics and 
academics with an interest in media ethics. Media-related ‘blogs’ are a key site of such criticism. The 
following comment about the Pfizer-funded workshops was, for example, published on the Knight 
Science Journalism Tracker Blog:[21] 
"When the National Press Foundation says in its annual report that it is funded, in part, by 
"concerned corporations," it's right on the money. You can bet that Pfizer, Merck, and the 
others are concerned about what appears in the press! ... The National Press Foundation 
apparently feels strongly that the press should be totally independent of government of any 
kind—but not of corporations." 
Critiques of industry-journalist relationships have also begun to emerge in the academic biomedical 
literature.[11, 13] Schwartz et al, for example, argued in a 2008 British Medical Journal article that 
such practices “raise disturbing questions about relations between industry and medical journalism, 
notwithstanding uncertainty about their extent or effect.” [11 p1203] 
Concern about industry-journalist relationships is also evident in many journalism codes of 
practice. The Association of Health Care Journalists, for example, argue that journalists should 
“(r)efuse gifts, favours, and special treatment.” And “(p)reserve a dispassionate relationship with 
sources, avoiding conflicts of interest, real or perceived.”[22] The Association also notes that 
journalists are themselves expected to act as watchdogs for conflict of interest among other 
professionals, and: 
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“Investigate and report the possible links between researchers and private companies, 
researchers and public institutions, patient advocacy groups and their sponsors, celebrity 
spokespersons and their sponsors, non-profit health and professional organizations and 
their sponsors”.  
This responsibility arguably makes it all the more important that journalists themselves should 
maintain their own independence from their sources. 
 
WHAT SHOULD BE DONE ABOUT INDUSTRY-JOURNALIST RELATIONSHIPS? 
In this context of aggressive corporate efforts to market products through the media, it 
could be argued that journalists should simply have no interactions with industry at all. But this 
ignores the fact that journalists need to interact with industry in order to inform the general public 
about commercial products and services.[18] Indeed, by providing accurate information about the 
potential benefits, harms and costs of products, journalists can help health consumers and health 
professionals to make informed decisions about healthcare and lifestyle. The aim of journalism 
should not be to exclude particular sources, or to avoid contact with interested groups. It should be 
to provide independent critical analysis of all sources, all claims and all interests—be they from 
industry or government, or the public or private sector. 
The question is not, therefore, whether journalists should interact with industry at all (or 
even whether such interactions are demonstrably bad). The question is how to manage industry 
influence without compromising the capacity of journalists to fulfil their professional roles. While 
interactions between journalists and their industry sources should ideally not involve gifts or 
financial transactions of any kind, the reality is that such transactions are rife and need to be 
addressed in a systematic and principled manner.  
We suggest that an examination of the approach taken to the identification and 
management of conflicts of interest in medicine provides some insights into strategies that might 
also have merit with regards to journalism. While medicine and journalism are fundamentally 
different activities, they are also alike in many ways. Like journalism, medicine is a virtuous 
profession that privileges independence, critical thinking and scepticism. And like journalism, 
medicine authoritatively shapes the construction of health and illness and the consumption of 
medicines and other health-related products and is thus a key target of the pharmaceutical industry. 
Medicine has also been forced to confront issues relating to its interactions with industry—including 
the failure of self-governance to prevent the proliferation of conflicts of interest and a loss of public 
trust. As a consequence, in recent years, a number of professional, legislative and regulatory 
strategies have been developed for managing the relationships between medical practitioners, 
medical researchers and industry. These include the mandatory requirements for declaration of 
conflict of interest in research, education and publication; conflict of interest registers in academic 
and health workplaces; restrictions on receipt of gifts, sponsorship and travel support from industry; 
and institutional guidelines relating to shareholding, educational sponsorship, participation on 
advisory panels, paid consultancies and so on. In addition, the pharmaceutical industry has been 
restricted by law and by industry code from certain types of interactions with the medical 
profession, with requirement for disclosure of sponsorship and prohibition of certain forms of 
promotion.[23] 
These strategies have had some success. Clinicians, researchers and professional bodies are 
now more attentive to issues raised by relationships with private industry. Identifying and managing 
potential conflicts of interest has become a topic in medical education and continuing medical 
education. And it is now mandatory to disclose such conflicts in (for example) the research 
publication process. Patients and the broader community are also much more aware of these issues 
and these relationships have generally become more transparent.[2, 24] 
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Similar strategies to those used in medicine could be used to manage conflict of interest in 
journalism. In response to changes in the relationships between journalists and industry, codes of 
ethics could continue to be developed, requiring for example that journalists disclose financial or in-
kind support relevant to each article or commentary piece. Transparency could also be formalised 
by, for example, establishing a publicly accessible register of relationships between industry and 
journalists, editors, media organisations and journalism organisations (including professional and 
educational bodies). But it may not be enough to focus only on transparency, as it is clear from other 
areas of professional practice that simply requiring disclosure is insufficient to change professional 
behaviour or prevent harm to the public.[4, 25, 26] Codes of conduct could, therefore, specify more 
clearly those journalist-industry relationships that are not acceptable (e.g. journalists reporting on 
products or services produced by companies in which they hold shares; or companies paying for the 
travel expenses of journalists’ families), as is the case with other professions such as medicine.  The 
profession might also consider opposing industry-sponsored prizes and educational endowments as 
these kinds of entanglements, while not tied to a particular product, are designed to create positive 
associations and risk turning the profession of journalism into a public relations arm of industry. And 
education and certification programs could be developed for journalists who report upon health, 
which would emphasise the risks of actual and perceived conflicts of interest.  
Currently, the profession of journalism relies primarily upon codes of practice and voluntary 
self-regulation.[e.g. 22] While the desire for self-governance is a mark of all professions, and the 
development of codes of ethics/practice is crucial, there is no evidence in any profession that codes 
of practice are sufficient to prevent unethical behaviour and they can only ever provide the public 
with limited reassurance that their interests are being respected.[4, 26, 27] Indeed, in the context of 
journalism, it is obvious that potentially harmful industry-journalist interactions are proliferating 
despite professional self-governance and the elaboration of professional codes of ethics. For this 
reason, while we agree with Schwartz et al. that journalists, educators and professional associations 
need “to scrutinise their own relationships with the industry as intensely as they do those between 
doctors and drug companies and to develop workable solutions”[11 p1203]—we feel that this is 
unlikely to be sufficient. 
For this reason, where countries regulate journalism, the above strategies could be 
mandated by law, with substantial fines for those who fail to comply (this would, of course, be 
difficult in the United States where the First Amendment to the US Constitution expressly protects 
the freedom of the press). In this regard, it is noteworthy that some countries have already 
instituted regulations of the kinds described above. In Portugal, for example, the state media 
regulatory body plays a major role in regulating journalistic activity. The law both promotes 
journalists’ freedom of expression and information (including the right to access and protect news 
sources) and makes demands of journalists (including demands for transparency about financing and 
property). It is also interesting to note that, despite the prominence of state media regulation in 
Portugal, professional self-regulation and citizens’ participation are seen as crucial to ensure that 
journalism fulfils its positive social functions and does not cause harm.[28]  
We do not wish to argue that all financial transactions should be discouraged by the 
profession, (and/or prohibited by law), as a matter of course. It could, for example, be possible to 
design processes for industry sponsorship where funds are not tied to a particular company or 
product (for example, by requiring de-identified grants to a centrally pooled educational fund). The 
important thing is that we have a comprehensive, nuanced, realistic and critical approach to 
managing relationships between industry and journalists.  These issues could be addressed as part of 
broader-ranging examinations of media practices and pharmaceutical industry regulation. 
Disentangling health-related journalism from its industry sources would be important not 
only for the profession of journalism, but also for the public (which, as discussed above, depends 
upon the news media for much of its health-related information) and for health professionals, who 
have an interest in their patients being informed participants in their own care and are obliged to 
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respond to misunderstandings that may result from the ways in which the media reports health-
related matters.  
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